Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation DGKD_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-11167 | DGKD | down-regulates | IRF7 | activates | R-2482 | 21 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-11168 | DGKD | down-regulates | IRF7 | activates | R-2486 | 21 | 4 | Drugs (1) |
CMF-11170 | DGKD | down-regulates | IRF7 | activates | R-2495 | 21 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-11171 | DGKD | down-regulates | EGR1 | activates | R-995 | 20 | 1 | Drugs (8) Regulator Drugs (0)Regulon Drugs (8)TAS0612, LANATOSIDE C, DIGOXIN, ACETYLDIGITOXIN, OCRIPLASMIN, DIGITOXIN, DESLANOSIDE, ISTAROXIME |
CMF-11176 | DGKD | down-regulates | PARP1 | activates | R-2374 | 11 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-37039 | DGKD | up-regulates | hsa-mir-340 | represses | R-2395 | 40 | 2 | Drugs (16) Regulator Drugs (0)Regulon Drugs (16)PONEZUMAB, CRENEZUMAB, ELIGLUSTAT, GANTENERUMAB, SOLANEZUMAB, ELIGLUSTAT TARTRATE, MIGLUSTAT, BAPINEUZUMAB, GSK933776, SATRALIZUMAB, LUCERASTAT, ADUCANUMAB, TRAMIPROSATE, LECANEMAB, DONANEMAB, VANUTIDE CRIDIFICAR |
CMF-37040 | DGKD | up-regulates | hsa-mir-340 | represses | R-1294 | 40 | 2 | Drugs (5) Regulator Drugs (0)Regulon Drugs (5)ELIGLUSTAT, ELIGLUSTAT TARTRATE, MIGLUSTAT, SATRALIZUMAB, LUCERASTAT |